De Backer Marianne 4
4 · Vir Biotechnology, Inc. · Filed Apr 4, 2024
Insider Transaction Report
Form 4
De Backer Marianne
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2024-04-03$9.46/sh−72,995$690,365→ 678,457 total
Footnotes (1)
- [F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.